United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

18 Apr 2019
Change (% chg)

$0.54 (+0.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Fuchs, Henry 

Dr. Henry J. Fuchs M.D. serves as Independent Director of the Company., effective September 17, 2013. Dr. Fuchs was Executive Vice President and Chief Medical Officer of Onyx Pharmaceuticals, Inc., a biopharmaceutical company from September 2005 to December 2008 and served in multiple roles of increasing responsibility at Ardea Biosciences, Inc., a biotechnology company, first as Vice President, Clinical Affairs, then as President and Chief Operating Officer, and finally as President and Chief Executive Officer, from October 1996 until June 2005. From 1987 to 1996, Dr. Fuchs held various positions at Genentech Inc., a biotechnology company. Dr. Fuchs serves as a director of Mirati Therapeutics, Inc. Dr. Fuchs holds a B.A. in Biochemical Sciences from Harvard University, and an M.D. from George Washington University.

Basic Compensation

Total Annual Compensation, USD 22,000
Restricted Stock Awards, USD 40,000
Long-Term Incentive Plans, USD --
All Other, USD 132,727
Fiscal Year Total, USD 194,727

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits


Gordon Cole


Steven Shak


Phillip Febbo


Laura Kammeyer


Frederic Pla

As Of  30 Dec 2017